NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31

NEUTRA CORP.

Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024

$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

NEUTRA CORP. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2023 2023-01-31	FY 2022 2022-01-31	FY 2021 2021-01-31	FY 2020 2020-01-31	FY 2019 2019-01-31	FY 2018 2018-01-31	FY 2017 2017-01-31	FY 2016 2016-01-31	FY 2015 2015-01-31	FY 2014 2014-01-31	FY 2013 2013-01-31	FY 2012 2012-01-31
Revenue	0.07	0.09	0.01	0.01	–	–	–	–	–	–	–	–
Cost of Revenue	0.03	0.06	0.04	–	–	–	–	–	–	–	–	–
Gross Profit	0.04	0.03	-0.03	0.01	–	–	–	–	–	–	–	–
General & Administrative	0.23	0.51	0.41	0.40	1.71	0.16	0.37	1.04	0.64	0.97	0.31	0.08
Advertising Expenses	–	–	–	–	–	–	–	–	–	0.09	0.00	0.00
Operating Income	-0.30	-0.58	-0.48	-0.39	-1.71	-0.16	-0.37	-1.04	-0.64	-0.97	-0.31	-0.08
Interest Expense	0.06	0.06	0.12	0.34	0.72	0.36	0.50	0.40	1.15	0.29	0.06	–
Other Non-Operating Income	-0.26	-0.05	-0.06	-0.30	-0.72	-0.36	-0.50	-0.41	-1.26	–	–	–
Pretax Income	-0.56	-0.63	–	–	–	–	–	–	–	–	-0.37	-0.08
Income Tax Expense	0.00	–	0.00	0	–	–	–	–	–	–	–	–
Net Income	-0.56	-0.63	-0.54	-0.70	-2.43	-0.52	-0.87	-1.44	-1.90	-1.26	-0.37	-0.08
Preferred Dividends	0.01	0.02	–	–	–	–	–	–	–	–	–	–
Net Income to Common	-0.58	-0.74	-0.58	-0.70	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	–	–	0.00	0.00	-0.16	-0.10	-0.41	-1.25	-3.36	-6.50	-8.00	-7.50
EPS (Diluted)(per share)	–	–	0.00	0.00	-0.16	-0.10	-0.41	-1.25	-3.36	-6.50	-8.00	-7.50
Shares Outstanding (Basic, Weighted)(shares)	–	–	1,193	242	15	5.26	2.14	1.15	0.56	0.19	0.05	0.01
Shares Outstanding (Diluted, Weighted)(shares)	–	–	1,193	242	15	5.26	2.14	1.15	0.56	0.19	0.05	0.01
EBITDA	-0.22	-0.51	-0.45	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Oct 31, 2023

Profitability, TTM

Gross margin: 46.2%
Operating margin: -1457.1%
Net margin: -2723.6%
Return on equity, FY2023: 54.9%

Financial strength

Current ratio: 0.02
Debt to equity: -0.06
Debt to assets: 201.0%
Cash to current liabilities: 0.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –